Kidron Nadav

Oramed Pharmaceuticals Inc.

President and CEO, Director

Avg. Two Year Performance

27% Avg. Purchase Return 13% Compound

< 1% Avg. Sale Return 0% Compound

Holdings: 1.91M shares

Last Three Months: 18-Feb-24 -- 17-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

18-May-22 -- 17-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions